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Rates of colonization with livestock-associated methicil-
lin-resistant Staphylococcus aureus (MRSA) sequence type 
398 have been high for pigs and pig farmers in Canada, but 
prevalence rates for the general human population are un-
known. In this study, 5 LA-MRSA isolates, 4 of which were 
obtained from skin and soft tissue infections, were identiﬁ  ed 
from 3,687 tested MRSA isolates from persons in Manitoba 
and Saskatchewan, Canada. Further molecular character-
ization determined that these isolates all contained staphy-
lococcal cassette chromosome (SCC) mecV, were negative 
for Panton-Valentine leukocidin, and were closely related by 
macrorestriction analysis with the restriction enzyme Cfr91. 
The complete DNA sequence of the SCCmec region from 
the isolate showed a novel subtype of SCCmecV harboring 
clustered regularly interspaced short palindromic repeats 
and associated genes. Although prevalence of livestock-as-
sociated MRSA seems to be low for the general population 
in Canada, recent emergence of infections resulting from 
this strain is of public health concern.
H
igh prevalence of colonization with livestock-associ-
ated (LA) methicillin-resistant Staphylococcus aureus 
(MRSA) sequence type (ST) 398 among pigs and pig farm-
ers was ﬁ  rst reported in the Netherlands (1) and has since 
been identiﬁ  ed in Canada (2) and the United States (3). In 
Canada, this LA-MRSA strain was identiﬁ  ed in pigs and 
pig farmers in southwestern Ontario, where prevalence of 
MRSA colonization was 24.9% (71/285) and 20% (5/25), 
respectively (2). In the United States, nasal samples from 
20 production system workers and 299 swine from 2 farms 
in Illinois and Iowa showed that 45% (9/20) and 49% 
(147/299), respectively, were colonized with LA-MRSA 
(3). Despite such high prevalence of MRSA colonization 
on these tested farms, to our knowledge, no human or ani-
mal infections resulting from LA-MRSA strains have been 
reported in North America.
To determine whether LA-MRSA has recently emerged 
in the general population of Canada, we identiﬁ  ed human 
infections and colonizations associated with the LA-MRSA 
strain in Canada and molecularly characterized the isolates. 
We also identiﬁ  ed a novel staphylococcal cassette chro-
mosome (SCC) mecV subtype harboring clustered regu-
larly interspaced short palindromic repeats (CRISPR) and 
CRISPR-associated genes (cas).
Materials and Methods
A convenience sample, totaling 2,358 MRSA iso-
lates from human specimens, was submitted to the Na-
tional Microbiology Laboratory (NML) for spa typing, 
as described (4,5). During January 2007–October 2008, 
the Saskatchewan Disease Control Laboratory submitted 
2,008 specimens; during October 2007–August 2008, the 
Cadham Provincial Laboratory in Manitoba submitted 
350 specimens. An additional 1,329 isolates from human 
specimens were spa typed by the Saskatchewan Disease 
Control Laboratory.
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Given the client base of the Cadham Provincial Labo-
ratory, most of these isolates would have originated from 
colonized and infected persons living in the community 
or in personal-care homes or from persons hospitalized 
in smaller community hospitals, whereas, for surveillance 
purposes, the Saskatchewan Disease Control Laboratory 
receives isolates from all colonized and infected persons 
across the province. Detailed information regarding why 
cultures were taken (e.g., screening admissions, outbreak 
investigations) and other clinical and epidemiologic data 
were limited. Isolates typed in this study represented ≈17% 
of all MRSA isolates from persons in Manitoba and ≈66% 
of all MRSA isolates from persons in Saskatchewan within 
the study period. An additional isolate was sent to the NML 
from Sunnybrook Health Sciences Centre in Ontario for 
reference purposes.
Isolates with spa types associated with ST398 were 
conﬁ  rmed by multilocus sequence typing; tested for Pan-
ton-Valentine leukocidin toxin, mecA, and nuc genes; and 
typed for SCCmec as described (6–9). Pulsed-ﬁ  eld gel elec-
trophoresis (PFGE) of SmaI- or Cfr91-digested genomic 
DNA was conducted as described (10). Antimicrobial drug 
susceptibility testing was conducted by using standard broth 
microdilution panels according to Clinical and Laboratory 
Standards Institute guidelines (11). Breakpoints for fusidic 
acid and mupirocin resistance, which were not provided in 
the guidelines, were as described (12,13).
A fosmid library was constructed by cloning sheared 
genomic DNA from S. aureus isolate 08 BA 02176 into 
the pCC2FOS vector. The fosmid clones were screened by 
PCR to identify speciﬁ  c genes orfX, mecA, and the chro-
mosomal region located downstream of SCCmec. Fosmid 
clone 1G1 was identiﬁ  ed and contained the entire SCCmec 
region of the 08 BA 02176 isolate. Colonies were prepared 
by using the CopyControl Fosmid Library Production Kit 
(Epicenter Biotechnologies, Madison, WI, USA) according 
to the manufacturer’s instructions. Fosmid DNA was col-
umn puriﬁ  ed by using a QIAGEN Plasmid Mini Kit (QIA-
GEN, Valencia, CA, USA).
DNA sequencing was performed on the ABI3730xl 
genetic analyzer (Applied Biosystems, Foster City, CA, 
USA). Staden (Pregap4) software was used to prepare trace 
data for sequence assembly (14). Sequencing reads were 
assembled by using the Staden Gap4 program. Gap closure 
was achieved by primer walking and long-range PCR. Spe-
ciﬁ  c primers were designed near the ends of neighboring 
contigs (contiguous sequence of DNA created by overlap-
ping sequenced fragments of a chromosome), and PCRs 
were performed with chromosomal template DNA. Re-
gions containing putative frameshifts and point mutations 
were resequenced to verify the ﬁ  delity of the sequence.
Annotation and data mining of the S. aureus 08 BA 
02176 1G1 fosmid clone sequence were performed by us-
ing the GenDB version 2.2 annotation tool (15). Putative 
protein coding sequences were determined according to 
coding sequence predictions of Glimmer, which is inte-
grated into the GenDB package. Similarity searches were 
performed by using BLASTN and BLAST2P (www.ncbi.
nlm.nih.gov/blast/Blast.cgi) against the nonredundant nu-
cleotide and protein databases, respectively. Additionally, 
a BLAST2P search was performed against the databases 
nr (ftp://ftp.ncbi.nlm.nih.gov/blast/db/), SWISS-PROT 
(www.expasy.ch/sprot/), and KEGG-Genes (ftp://ftp.ge-
nome.jp/pub/kegg/genes/); the protein family databases 
Pfam (http://pfam.sanger.ac.uk/) and TIGRFAM (www.
jcvi.org/cms/research/projects/tigrfams/overview/); and 
predictive signal peptide (Signal P [www.cbs.dtu.dk/
services/SignalP/]) and transmembrane helix analysis 
(TMHMM [www.cbs.dtu.dk/services/TMHMM/]), the 
nonredundant database on protein level. An automatic 
functional annotation was followed by a manual annota-
tion of each predicted gene.
Results
LA-MRSA Characterization
A total of 3,687 MRSA isolates were examined; 5 con-
tained ST398-associated spa types (4 t034 and 1 t1250). 
The additional isolate submitted to NML by Sunnybrook 
Health Sciences Centre in Ontario, isolate T40929, also 
contained a t034 spa type. Further molecular character-
ization of these 6 isolates determined that they were all 
ST398, SCCmecV, and negative for the Panton-Valentine 
leukocidin–encoding genes (Table 1). Of the 6 isolates, 5 
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Table 1. Characteristics of methicillin-resistant Staphylococcus aureus sequence type 398 novel staphylococcal cassette chromosome 
mecV subtype isolates, Canada* 
Isolate Collection date  Patient age, y/sex  Region and province   Specimen collection site  spa type 
07 BA 06477  2007 Feb 27  26/F  Saskatoon, SK  Nasal screen  t034
08 BA 02176  2008 Jan 15  71/F  Sunrise, SK  Leg swab  t034
08 BA 08100  2008 Mar 4  51/M Five Hills, SK  Left shin open abrasion  t1250 
08 BA 13895  2008 Apr 25  79/M Kelsey Trail, SK  Left hip swab  T034 
08 BA 22334  2008 Jul 9  70/M Prince Albert Parkland, SK Right leg swab  T034 
T40929  2007 Dec 11  59/M Durham, ON  Nasal and tracheostomy 
screen
T034 
*All isolates were Panton-Valentine leukocidin negative. SK, Saskatchewan; ON, Ontario. Livestock-associated MRSA ST398 in Humans
were resistant to tetracycline, but all were susceptible to the 
other 12 antimicrobial drugs tested (Table 2).
From the surveillance in Manitoba and Saskatchewan, 
patient information was limited and showed no geographic 
links (all 5 persons resided in different health regions but 
were all within the southeastern portion of Saskatchewan) 
(Figure 1). Of the 5 isolates, 4 were obtained from infected 
persons (average age 67.8 years, range 51–79 years) (Table 
1). The earliest identiﬁ  ed LA-MRSA isolate (08 BA 2176) 
associated with an infection was obtained from a postopera-
tive surgical site. Further follow-up was not possible because 
of the patient’s health problems. This patient is unlikely to 
have had any recent direct contact with livestock because 
she had been conﬁ  ned to her home with limited mobility 
for several years before her hospitalization. Additional na-
sal swabs from this patient remained positive for this strain 
for at least 7 months. Additional clinical and epidemiologic 
information for the remaining 3 patients with skin and soft 
tissue or wound infections were limited (Table 1).
The isolate submitted to the NML by Sunnybrook 
Health Sciences Centre, outside the surveillance program, 
was from a 59-year-old man from Ontario. He had been 
hospitalized in December 2007 for treatment of metastatic 
squamous cell carcinoma of the larynx. In the previous 
year, he had undergone a total laryngectomy, neck node 
dissection, and tracheostomy. A MRSA isolate was recov-
ered from screening specimens from his nose and the tra-
cheostomy site that had no indication of infection. He was 
unaware of any animal contact and had no history of expo-
sure to pigs or pig farms. A review of the medical records 
and standard epidemiologic investigations determined that 
this was not a nosocomial or healthcare-associated isolate.
The 6 LA-MRSA isolates were nontypeable by PFGE 
using SmaI. However, PFGE using the neoschizomer Cfr91 
showed that the 6 LA-MRSA isolates were closely related 
(Figure 2, panel A). Control MRSA strains digested indi-
vidually with either Cfr91 or SmaI showed no differences 
in ﬁ  ngerprint banding patterns when the 2 enzymes were 
compared (data not shown), which enabled comparisons 
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Table 2. Antimicrobial drug susceptibility of the clinical isolates of methicillin-resistant Staphylococcus aureus sequence type 398, 
Canada, 2008*  
Drug 
Susceptibility, Pg/mL 
07 BA 06477  08 BA 02176  08 BA 08100  08 BA 13895  08 BA 22334  T40929 
Clindamycin <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 
Vancomycin  0.5 0.5 0.5 0.5 0.5  0.5 
Erythromycin  0.5 0.5 0.5 0.5 0.5  0.5 
SXT <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 
Synercid 0.5  1  <0.25 <0.25 <0.25 <0.25 
Nitrofurantoin <32 <32 <32 <32 <32 <32 
Tetracycline >16 >16 >16  2 >16  >16 
Ciprofloxacin  0.5 0.25 0.5 0.25 0.5  0.5 
Rifampin <0.25 <0.25 <0.25 <0.25 <0.25 <0.25 
Fusidic  acid 0.25 0.12 0.25 0.12 0.12  0.12 
Linezolid 2  2  2  1  0.5  0.5 
Gentamicin  1 1 1 1  0.5 1 
Mupirocin 0.5  0.25  <0.12 <0.12 0.25  <0.12 
*SXT, sulfamethoxazole/trimethoprim. 
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Figure 1. Geographic distribution of 5 livestock-associated 
methicillin-resistant  Staphylococcus aureus isolates (stars) from 
humans, Saskatchewan, January 2007–October 2008.RESEARCH
of the PFGE patterns obtained for the LA-MRSA isolates 
with those of other epidemic MRSA strains from hospi-
tals and communities in Canada. No close relatedness was 
found (>7 bands difference; <80% similarity) between the 
LA-MRSA isolates and any other epidemic MRSA strain 
circulating in Canada (Figure 2, panel B).
SCCmec Characterization
DNA sequencing of the entire SCCmec element from 
isolate 08 BA 02176 showed a 32,369-bp element integrat-
ed at the 3′ end of orfX containing 30 putative open reading 
frames (ORFs) (Figure 3; Table 3). This element carried a 
class C2 mec complex, which putatively contained a non-
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Figure 2. A) Pulsed-ﬁ  eld gel electrophoresis (PFGE) of Cfr91-digested livestock-associated methicillin-resistant Staphylococcus aureus 
(MRSA). Lanes 1, 6, and 9, universal standard Salmonella Braenderup H9812; Lane 2, 08 BA 02176; Lane 3, 08 BA 13895; Lane 4, 07 
BA 06477; Lane 5, T40929; Lane 7, 08 BA 08100; Lane 8, 07 BA 22334. B) PFGE dendrogram comparing the Cfr91 ﬁ  ngerprint patterns 
of 6 livestock-associated MRSA isolates from humans in Canada with the SmaI ﬁ  ngerprints of other human epidemic strains of MRSA 
circulating in Canada.
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GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TCTATAAGTTCATTAATTCCGATACCTAGATTATCT
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TTTTTTCCACCCTTTCAGATCATCTATGATCTTG
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT AATTTTCTAATTCTATAAGTTCATTAATTCCGAT
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TATACTATTTACATAATTTTTTATGTGTCTGTCTAC
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TAATAGTGTTGTTCTCTATTAAAAGATACAATCCTGT
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TAGAATGTTATTATCTAAGTGGTCGATGTATTCC
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TCATACTAGCACCCCACTCTCTACTGAACAAGTATCA
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT CTTAAAATCTAATTGCATTGTTATCAATTCCTTTA
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TCTGTAATGTATTCATTTAATGTAATCATAATTTTTTC
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TAGACCATTTACCTCATTATATTTATAGTCTTTATTA
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT TTTTCTTTAACTGTTTTTACTGCCCATTTAATAGT
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT ATATTTCTTCCATGAATAACACCCTCCTTTTTTCTA
GATCGATAACTACCCCGAATAACAGGGGACGAGAAT AAGTTAACGGCATTACCTAATAAAAATATTTTAGG
GATCGATAACTACCCCGAATAACAGGGGACGAGAAC TCATCTTTCATGTCACTGATTAATTCATTTGTA
GATCGATAACTACCCCGAATAACAGGGGACGAGAAC GGTAATAGTTGCTCAATAGGTAATAAAACGTCGGT
GATCGATAACTATCCCGAATAACAGGGGACAGAGTG
Direct repeat consensus Spacers
J3 J2 J1
Figure 3. Schematic of the novel staphylococcal cassette chromosome (SCC) mecV subtype and DNA sequence of the clustered regularly 
interspaced short palindromic repeat (CRISPR) array identiﬁ  ed in Staphylococcus aureus isolate 08 BA 02176. Red and green arrows 
represent mec and ccr complexes, respectively. Blue arrows represent 3 open reading frames (ORFs) in the J3 region sharing sequence 
identity with chromosomal genes of S. epidermidis RP62A. Orange boxes indicate conﬁ  rmed and questionable CRISPRs. Black arrows 
represent CRISPR-associated genes. Location of primer sets used for coverage of this SCCmec element are numbered 1–11 (Table 4) 
and illustrated as solid lines. Shown below the schematic is the DNA sequence of the conﬁ  rmed 1,107-bp CRISPR array in the J1 region, 
which provides the 36-bp direct repeat consensus (boldface) and the variable 15 spacer sequences.Livestock-associated MRSA ST398 in Humans
functional IS431 transposase and a type 5 ccr gene com-
plex (ccrC2). Other than mecA, no additional antimicrobial 
drug resistance genes were identiﬁ  ed within this element.
The  ﬁ   rst unique feature of this SCCmecV element 
included 3 ORFs in the J3 region sharing high sequence 
identity with ORFs from S. epidermidis RP62A (Gen-
Bank accession no. CP000029), which included an ADP-
ribosylglycohydrolase, a permease for cytosine/purines, 
and a ribokinase (Table 3). A second unique feature was 
a CRISPR array, identiﬁ  ed by using CRISPRFinder (16), 
in the J1 region, which appears to have replaced the type 1 
restriction modiﬁ  cation system (hsdR, hsdS, hsdM) through 
recombination. The CRISPR array (1,107 bp) contained a 
36-bp direct repeat consensus and 15 spacers of variable 
sequence and length (33–38 bp) (Figure 3). Downstream 
of this CRISPR array was a combination of putative CRIS-
PR-associated (cas) genes, sharing sequence identity with 
those previously identiﬁ  ed in S. epidermidis RP62A. This 
array was followed by a second questionable CRISPR ar-
ray (183 bp) containing a 38-bp direct repeat consensus and 
2 spacers of variable sequence (Figure 3; Table 3).
Design of primers spanning the entire SCCmec ele-
ment was based on the DNA sequence obtained from 08 
BA 02176 (Figure 3; Table 4). PCR of these select regions 
produced amplicons of expected size for 3 additional LA-
MRSA isolates (07 BA 06477, 08 BA 13895, 08 BA 22334) 
but were negative for some of the J1 and J3 regions in 08 
BA 08100 and T40929 (Table 4).
Discussion
The high prevalence of LA-MRSA colonization of 
pigs and pig farmers in Canada (2) and the United States 
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Table 3. Open reading frames of the novel staphylococcal cassette chromosome mecV subtype in methicillin-resistant Staphylococcus
aureus  isolate 08 BA 02176, from woman in Canada, 2008* 
ORF Location,  bp† 
Predicted 
gene size, bp  Gene‡ Product  description 
Amino acid 
identity, %§ 
GenBank 
accession no. 
Sk01 1–480  480  orfX  Conserved hypothetical protein  100  gb|ACC96139.1| 
Sk02 609–1595  987  None  ADP-ribosylglycohydrolase  99  gb|AAW53059.1| 
Sk03  1614–2948  1335  None  Permease for cytosine/purines; uracil; 
thiamine; allantoin 
98 gb|AAW53058.1| 
Sk04 2999–3883  885  None  Ribokinase  98  gb|AAW53057.1| 
Sk05 (4013–4687)  675  tnp  Transposase for IS431  100  dbj|BAD24823.1| 
Sk06  4945–5112  168  None  HMG-CoA synthase truncation  100  ref|YP_184940.1| 
Sk07 6029–6772  744  ugpQ  Glycerophosphoryl diester 
phosphodiesterase 
100 ref|NP_370563.1| 
Sk08 6869–7297  429  maoC  Hypothetical protein  100  ref|YP_184943.1| 
Sk09 (7343–9349)  2007  mecA  Penicillin-binding protein 2ƍ 100  dbj|BAG06200.1| 
Sk10 9449–9559  Unknown  ȥmecR1  Truncated signal transducer protein MecR1  100  ref|YP_252007.1| 
Sk11 9597–9740  144  ȥtnp  Partial transposase for insertion sequence–
like element IS431mec 
100 dbj|BAH57698.1| 
Sk12 (10331–10759)  429  None  Hypothetical  protein  100  dbj|BAD24829.1| 
Sk13 10840–11769  930  None  Hypothetical  protein  100  gb|ACL99839.1| 
Sk14 11931–13919  1989  None  Hypothetical  protein  100  gb|ACL99840.1| 
Sk15 14114–15223  1110  None  Hypothetical  protein  100  gb|ACL99841.1| 
Sk16 15584–17200  1617  None  Hypothetical  protein  100  gb|ACL99843.1| 
Sk17 17425–19104  1680  ccrC  Cassette chromosome recombinase C  100  gb|ACL99844.1| 
Sk18 19193–19531  339  None  Hypothetical  protein  100  gb|ACL99845.1| 
Sk19 19625–19936  312  None  Hypothetical  protein  100  gb|ACL99846.1| 
Sk20 19951–20454  504  None  Hypothetical  protein  100  gb|ACL99847.1| 
Sk21 20469–20690  222  None  Hypothetical  protein  100  gb|ACL99848.1| 
Sk22 (20853–21256)  403  ȥhsdR Truncated  hsdR 92  dbj|BAG71456.1| 
Sk23 22888–23793  906  cas1  CRISPR–associated Cas1 family protein  91  gb|AAW53332.1| 
Sk24 23793–24098  306  cas2  CRISPR-associated protein Cas2  87  gb|AAW53331.1| 
Sk25 24112–26385  2274  csm1  CRISPR-associated protein; Csm1 family  92  gb|AAW53330.1| 
Sk26 26388–26813  426  csm2  CRISPR-system related protein  94  gb|AAW53329.1| 
Sk27 26815–27459  645  csm3  CRISPR-associated RAMP protein  96  gb|AAW53328.1| 
Sk28 27530–28378  849  csm4  CRISPR-associated RAMP protein  91  gb|AAW53327.1| 
Sk29 28381–29403  1023  csm5  CRISPR-associated Csm5 family protein  92  gb|AAW53326.1| 
Sk30 29403–30671  1269  csm6  CRISPR-associated protein (Cas_Csm6)  73  gb|AAW53325.1| 
Sk31 30668–31402  735  cas6  CRISPR-associated protein C  86  gb|AAW53324.1| 
*ORF, open reading frame; CRISPR, clustered regularly interspaced short palindromic repeats. 
†Parentheses indicate complement sequences. 
‡None indicates no name given. 
§Comparisons of translated query versus protein databases was determined by using BLASTX 2.2.21 (www.ncbi.nlm.nih.gov/blast/Blast.cgi). RESEARCH
(3) and this report of human infections suggest that this 
LA-MRSA strain from Canada poses potential public and 
occupational health concern in North America. This strain 
has been associated with various types of infections in pigs 
(17,18) and humans (19,20) and is transmissible from ani-
mal patients to veterinary workers (21), healthcare workers 
(22), and family members (1). Evidence also suggests that 
this strain might be spreading from animals to the environ-
ment, which may facilitate the colonization or infection of 
persons who are not involved in animal husbandry (23). 
Whereas in 2006 in the Netherlands LA-MRSA account-
ed for >20% of all MRSA isolated (24), carriage of this 
strain in the general population of 2 provinces in Canada 
(Manitoba and Saskatchewan) appears rare (0.14%). This 
difference could be attributed to the substantially higher 
density of pigs in the Netherlands (1,244 pigs/km2) than 
in Manitoba (55 pigs/km2), Saskatchewan (6 pigs/km2), 
and Ontario (91 pigs/km2) (www.agriculture.gov.sk.ca/
Pig_Densities). It is also plausible that the much lower 
proportions of LA-MRSA in Canada, relative to a coun-
try with low MRSA endemicity such as the Netherlands, 
is attributable to competition with other highly success-
ful human epidemic MRSA clones circulating in Canada, 
including CMRSA2 (USA200/800), CMRSA7 (USA400), 
and CMRSA10 (USA300) (25,26).
The tested LA-MRSA isolates were highly susceptible 
to most classes of antimicrobial drugs, except β-lactams 
and tetracyclines, the latter of which has been attributed 
to its high usage in animal husbandry (27). The complete 
sequence of the SCCmec region showed a novel SCC-
mecV subtype sharing sequence identity in its J1 and J3 
regions with chromosomal genes in the S. epidermidis 
RP62A chromosome (GenBank accession no. CP000029), 
including a CRISPR system. CRISPRs and associated cas 
genes are present in many other bacterial (≈40%) and ar-
chaeal (≈90%) genomes (28,29) and have been shown to 
be involved in sequence-directed immunity against phages 
(30,31) and plasmids (32). The resistance to plasmids and 
phages encoded by this system could explain why many of 
these ST398-MRSA-V strains contain fewer antimicrobial 
drug resistance genes and phage-encoded virulence factors 
than do other epidemic MRSA strains (33,34). The origin 
of this CRISPR system is unknown, but the propagation of 
CRISPR loci throughout prokaryote genomes has been pro-
posed to occur through horizontal gene transfer by conju-
gation of megaplasmids >40 kb (35). Because the CRISPR 
system identiﬁ  ed in this study is encoded within a puta-
tive mobile genetic element, we propose that an additional 
mechanism of mobilization to other methicillin-susceptible 
Staphylococcus spp. is plausible.
This novel subtype of SCCmecV was found in only 
4 of the 6 LA-MRSA isolates identiﬁ  ed in this study. One 
isolate not containing this novel SCCmec subtype (08 BA 
08100) could also be distinguished by a different but closely 
related spa type (t1250) (Table 1) and variant PFGE ﬁ  nger-
print (Figure 2) when compared with the other LA-MRSA 
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Table 4. Primers used for coverage of the novel SCCmecV subtype in methicillin-resistant Staphylococcus aureus isolates, Canada, 
2007–2008* 
Primer 
set 
Primer 
name  Primer  5ƍ o 3ƍ 
Expected 
amplicon 
size, bp 
Reference 
position 
SCCmecV found in isolate 
08 BA 
02176
T 
49209
07 BA 
06477 
08 BA 
13895 
08 BA 
08100
08 BA 
22334
1 OrfX 
Adpr1 
CATTTAAGATTATGCGTGGAG 
CATCTGTAAACTGTCCTTTGG 
347 443–789  +  –  +  +  –  + 
2 RibB2 
MecaA1 
TTGTATATGGGGAAACGAAG 
TGCCAAAATCTCAGGTAAAG 
3623 3793–7415 +  –  +  +  –  + 
3 MecB1 
HypA1 
CTTCACCATTATCGCTTTTAG 
ACCATTTTTCCCTGGATTAC 
1842 9172–11013 +  +  +  +  +  + 
4 Hyp3A1 
Hyp1B1 
CTTCCACGTATTGGTCTAGC 
AAGTGAACGCGAAAGATATAG 
2671  11636–14306  + + + + + + 
5 Hyp3B1 
CcrCA2 
GCTAGACCAATACGTGGAAG 
TTTTACCTGAAATGCCTGAG 
3301  14287–17587  + + + + + + 
6 CcrCB1 
Hyp6A1 
ATGAAATGGATAGCGAAATG 
TTGAGTAAGTAGCGGTGTTG 
1330  18695–20024  + + + + + + 
7 Hyp6B1 
Crspr1A1 
TGAGCAAGTGATGGAAATG 
CTTTGAATCCTTTGAAGACG 
2835 20331–23165 +  –  +  +  –  + 
8 Crspr1B1 
Crspr3A1 
AAAAAGTGGTGAGGTTACTTG 
CTCGTCTATCAATACCACTCG 
711 23675–24385  +  –  +  +  –  + 
9 Crspr3B1 
Crspr7A1 
AACAGATGAACACGGAAAAG 
TTGGTGGGTATCTCAAAAAG 
2417 26166–28582 +  –  +  +  –  + 
10 Crspr7B1 
Hyp11A1 
GCCTTCTAACGTACCAGTTG 
TTGCTTCAATGGACTATAAGC 
1511 29289–30820 +  –  +  +  –  + 
11 Hyp11B1 
Hyp12A1 
TTAGGCATGGGGAAATATAG 
GTCGCAATGTTTTGAAGTG 
1622 31373– +  –  +  +  –  + 
*SCCmec, staphylococcal cassette chromosome mecV subtype; +, positive; –, negative. Testing by PCR. Livestock-associated MRSA ST398 in Humans
isolates, which suggests that at least 2 epidemiologically 
different strains of LA-MRSA circulate in Saskatchewan. 
The other LA-MRSA isolate that did not contain this novel 
SCCmec element was obtained in Ontario. However, this 
isolate was the same spa type (t034) and was closely relat-
ed, according to PFGE, to the LA-MRSA isolates identiﬁ  ed 
in Saskatchewan. Therefore, in addition to PFGE and spa 
typing, SCCmec subtyping could provide a useful epide-
miologic tool for surveillance, outbreak investigations, or 
traceability studies of this emerging strain. For detection 
of this SCCmecV subtype (tentatively designated V.2.1.2; 
Vb), we propose using primer set 1 (spanning orfX into 
Sk02 in the J3 region) and primer set 7 (spanning Sk20 into 
cas1 in the J1 region) (Table 4).
Visual comparison of PFGE ﬁ   ngerprints from this 
study with those reported from patients from the Domini-
can Republic and the United States (northern Manhattan, 
New York, NY) (36), showed substantial variations in ﬁ  n-
gerprint patterns, as well as related but different spa types. 
These variations suggest further molecular and geographic 
diversity of these LA-MRSA strains on a global scale.
Because cases of LA-MRSA infections have only re-
cently been identiﬁ  ed in Canada, additional surveillance 
efforts are required to monitor the emergence and clinical 
relevance of this MRSA strain in Canada, including com-
munities, the environment, livestock, farmers, and produc-
tion facility workers. Whether these strains pose a major 
threat to human health in light of the low livestock density 
and continued spread of epidemic hospital and community 
strains of MRSA in Canada remains unknown.
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